Advertisements


Raymond James says Viking volatility on GTx trial failure would be chance to buy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 21st, 2018

Viking Therapeutics downgraded to outperform from strong buy at Raymond James

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 25th, 2021

Viking Therapeutics downgraded to Outperform from Strong Buy at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 25th, 2021

Raymond James cuts NGM Biopharmaceuticals to Outperform after NASH trial miss

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 24th, 2021

MarketAxess upgraded to Outperform amid market volatility at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 13th, 2020

Raymond James trading halted, volatility trading pause

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 9th, 2020

Raymond James Downgrades Ocular Therapeutix, Remains Bullish On Pipeline

Ocular Therapeutix Inc (NASDAQ: OCUL)'s failure to ace a late-stage study of its glaucoma treatment candidate has tempered Raymon.....»»

Category: blogSource: benzingaMay 21st, 2019

Viking Therapeutics initiated with an Outperform at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2018

Viking NAFLD data beat "optimistic expectations," says Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 18th, 2018

Viking price target raised to $43 after Phase 2 data at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 18th, 2018

Viking Therapeutics stock price target raised to $43 from $15 at Raymond James

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchSep 19th, 2018

Adaptimmune"s stock tumbles after cancer study results prompts price target cut

Shares of Adaptimmune Therapeutics PLC slumped 21% in morning trade Monday, after the results from a trial of its cancer treatment prompted Raymond James to slash its price target. The biopharmaceutical company.....»»

Category: topSource: marketwatchOct 22nd, 2018

What stock volatility means for investors, according to Raymond James’ CEO

Raymond James CEO Paul Reilly told FOX Business that investors shouldn’t panic over volatility that’s sweeping through U.S. financial markets......»»

Category: topSource: foxnewsOct 25th, 2018

Viking Therapeutics upgraded to Strong Buy from Outperform at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2018

Viking Therapeutics upgraded to Strong Buy at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2018

Viking Has A More Attractive M&A Valuation Than Madrigal, Raymond James Says In Upgrade

Viking Therapeutics Inc (NASDAQ: VKTX), which focuses on therapies for metabolic and endocrine disorders, recently presented Phase 2 data for its non-alcoholic fatty li Latest Ratings for V.....»»

Category: blogSource: benzingaNov 19th, 2018

iRobot Shares Likely To Be Less Volatile Post-Q4 Print, Analyst Says

iRobot Corporation (NASDAQ: IRBT) investors should brace for less volatility this year, according Raymond James. The Analyst Analyst Brian Gesuale has a Market Perform rating on iRobot. .....»»

Category: blogSource: benzingaJan 15th, 2019

Crib-Notes For The "Trial Of The Century"

Crib-Notes For The 'Trial Of The Century' Authored by James Howard Kunstler via Kunstler.com, “Once someone determined Trump was so bad it was okay to lie about him, it set the preceden.....»»

Category: smallbizSource: nytApr 15th, 2024

Ventas price target raised to $61 from $54 at Raymond James

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 25th, 2021

89bio downgraded to outperform from strong buy at Raymond James

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 25th, 2021

Ventas stock price target raised to $61 from $54 at Raymond James

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 25th, 2021